Cargando…
Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing
Allogeneic T cells are key immune therapeutic cells to fight cancer and other clinical indications. High T cell dose per patient and increasing patient numbers result in clinical demand for a large number of allogeneic T cells. This necessitates a manufacturing platform that can be scaled up while r...
Autores principales: | Gatla, Himavanth, Uth, Nicholas, Levinson, Yonatan, Navaei, Ali, Sargent, Alex, Ramaswamy, Senthil, Friedrich Ben-Nun, Inbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189297/ https://www.ncbi.nlm.nih.gov/pubmed/35707712 http://dx.doi.org/10.3389/fmedt.2022.850565 |
Ejemplares similares
-
The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors
por: Bayley, Rachel, et al.
Publicado: (2017) -
Transition from static culture to stirred tank bioreactor for the allogeneic production of therapeutic discogenic cell spheres
por: Rodriguez-Granrose, Daniel, et al.
Publicado: (2021) -
Production of bioherbicide by Phoma sp. in a stirred-tank bioreactor
por: Brun, Thiarles, et al.
Publicado: (2016) -
End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
por: Pandey, Puspa R., et al.
Publicado: (2019) -
Evaluation of a disposable stirred tank bioreactor for cultivation of mammalian cells
por: Hähnel, Alexander, et al.
Publicado: (2011)